Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, Illinois, USA.
World Neurosurg. 2023 Jul;175:e439-e446. doi: 10.1016/j.wneu.2023.03.120. Epub 2023 Apr 5.
We assessed the potential effect of the preoperative symptom duration on patient-reported outcomes (PROs) for workers' compensation (WC) patients undergoing minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF).
WC patients who had undergone primary, elective MIS-TLIF with recorded symptoms duration data available were included. Two cohorts were generated: those with a shorter (lesser) duration (LD; symptom duration <1 year) and those with a prolonged duration (PD; symptom duration >1 year). PROs were collected preoperatively and at several follow-up points for ≤1 year postoperatively. The PROs were compared within and between the 2 cohorts. The achievement rates of minimum clinically important differences were also compared between the 2 cohorts.
A total of 145 patients were included, with 76 in the PD cohort and 69 in the LD cohort. The LD cohort demonstrated improvement in the patient-reported outcomes measurement information system for physical function (PROMIS-PF) at 6 months and 1 year postoperatively, Oswestry disability index (ODI) at 12 weeks and 6 months postoperatively, visual analog scale (VAS) score for back pain at 6 weeks, 12 weeks, and 6 months postoperatively, and VAS score for leg pain at all postoperative points (P ≤ 0.015 for all). The PD cohort demonstrated improvement in the PROMIS-PF at 12 weeks and 6 months postoperatively, ODI at 6 weeks, 12 weeks, and 6 months postoperatively, and VAS score for back pain and leg pain at all postoperative periods (P ≤ 0.007 for all). All the preoperative PROs were superior for the LD cohort (P < 0.001 for all). The LD cohort reported better PROMIS-PF at 6 months and 1 year and ODI at 1 year postoperatively (P ≤ 0.037 for all). The PD cohort was more likely to achieve a minimum clinically important difference in ODI at 6 and 12 weeks postoperatively, VAS score for back pain at 6 weeks postoperatively, and VAS score for leg pain at 6 weeks and 1 year postoperatively and overall (P ≤ 0.036 for all).
Independently of the preoperative symptom duration, WC patients demonstrated improvement in physical function and pain after MIS-TLIF. Patients with a longer symptom duration reported inferior function and pain preoperatively and were more likely to demonstrate clinically significant improvements in disability and pain postoperatively.
我们评估术前症状持续时间对接受微创经椎间孔腰椎体间融合术(MIS-TLIF)的工人赔偿(WC)患者患者报告的结局(PROs)的潜在影响。
纳入了接受过原发性、择期 MIS-TLIF 且记录有症状持续时间数据的 WC 患者。生成了两个队列:症状持续时间较短(<1 年)的患者为短病程(LD)队列,症状持续时间较长(>1 年)的患者为长病程(PD)队列。在术后≤1 年内的多个随访点收集 PROs。比较了两个队列内和队列间的 PROs。还比较了两个队列间的最小临床重要差异的达标率。
共纳入 145 例患者,其中 PD 队列 76 例,LD 队列 69 例。LD 队列在术后 6 个月和 1 年时的患者报告的测量信息系统物理功能(PROMIS-PF)、术后 12 周和 6 个月时的 Oswestry 残疾指数(ODI)、术后 6 周、12 周和 6 个月时的视觉模拟量表(VAS)腰痛评分以及所有术后点的 VAS 腿痛评分均得到改善(所有 P≤0.015)。PD 队列在术后 12 周和 6 个月时的 PROMIS-PF、术后 6 周、12 周和 6 个月时的 ODI,以及所有术后时段的腰痛和腿痛的 VAS 评分均得到改善(所有 P≤0.007)。LD 队列的所有术前 PROs 均优于 PD 队列(所有 P<0.001)。LD 队列在术后 6 个月和 1 年时的 PROMIS-PF 和 ODI 更好(所有 P≤0.037)。PD 队列在术后 6 和 12 周时的 ODI、术后 6 周时的腰痛 VAS 评分以及术后 6 周和 1 年时的腿痛 VAS 评分和总体的最小临床重要差异达标率更高(所有 P≤0.036)。
独立于术前症状持续时间,WC 患者在接受 MIS-TLIF 后在身体功能和疼痛方面均有改善。症状持续时间较长的患者术前功能和疼痛较差,术后在残疾和疼痛方面更有可能表现出明显的改善。